UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
FORM 4
[ ] Check this box if no longer OMB APROVAL
subject to Section 16. Form 4 or OMB NUMBER: 3235-0287
Form 5 obligations may continue. Expires: September 30, 2000
See Instruction 1(b). Estimated average burden
hours per response........0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
1. Name and Address of Reporting Person*
Morgan Stanley Venture Capital II, Inc.(1)
-----------------------------------------------------------------------------
(Last) (First) (Middle)
1221 Avenue of the Americas
----------------------------------------------------------------------------
(Street)
New York NY 10020
-----------------------------------------------------------------------------
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lionbridge Technologies, Inc. (LIOX)
-----------------------------------------------------------------------------
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)
-----------------------------------------------------------------------------
4. Statement for Month/Year
11/2000
-----------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Day/Year)
-----------------------------------------------------------------------------
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
Director X 10% Owner
--- ---
Officer (give title below) Other (specify below)
--- ---
----------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
----
X Form filed by More than One Reporting Person
----
<PAGE>
Table I -- Non-Derivative Securities Acquired, Disposed of or
Beneficially Owned
<TABLE>
1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired 5. Amount of Securities 6. Ownership 7. Nature of
(Instr. 3) action action (A) or Disposed of Beneficially Owned Form: Direct Indirect
Date Code (D) (Instr. 3, 4 at End of Month (D) or In- Beneficial
(Instr.8) and 5) (Instr. 3 and 4) direct (I) Ownership
(Month/ (Instr. 4) (Instr. 4)
Day/ (A) or
Year) Code V Amount (D) Price
------------------------- --------- ---- --- ------- --- --------- -------------------- -------------- -------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Common Stock 11/28/00 J(2) 1,500,000 D 0 3,119,340 I through
participation
Common Stock 11/28/00 J(3) 305,228 A 0 3,424,568 I(4) through
participation
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
(Over)
SEC 1474 (7-96)
<PAGE>
FORM 4 (continued)
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
1. Title of 2. Conversion or 3. Transaction Date 4. Transaction 5. Number of 6. Date Exercisable and
Derivative Exercise Price (Month/Day/Year) Code Derivative Expiration Date
Security of Derivative (Instr. 8) Securities (Month/Day/Year)
(Instr. 3) Security Acquired (A)
or Disposed of
(D) (Instr. 3,
4 and 5)
Date Expiration
Code V (A) (D) Exercisable Date
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
1. Title of 7. Title and Amount of 8. Price of 9. Number of 10. Ownership 11. Nature of
Derivative Underlying Securities Derivative derivative Form of Indirect
Security (Instr. 3 and 4) Security Securities Derivative Beneficial
(Instr. 3) (Instr. 5) Beneficially Security: Ownership
Amount Owned at End Direct (D) (Instr. 4)
or of Month or Indirect
Number (Instr. 4) (I)
of (Instr. 4)
Title Shares
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
Partnership (5)
</TABLE>
Explanation of Responses:
(1) Please see attached Joint Filer Information.
(2) Morgan Stanley Venture Capital Fund II Annex, L.P. and Morgan Stanley
Venture Investors Annex, L.P. (collectively, the "Funds"), of which Morgan
Stanley Venture Capital II, Inc. ("MSVC II, Inc.") is the managing general
partner of Morgan Stanley Venture Partners II, L.P., the General Partner
of the Funds, made an in-kind distribution (the "Distribution") of shares
of Common Stock. The reported securities were distributed to the Funds'
partners in proportion to their partnership interests in the Funds.
(3) MSVC II, Inc. received 305,228 shares of the Common Stock in the
Distribution.
(4) Except for the 305,228 shares of Common Stock which are held directly by
MSVC II, Inc., MSVC II, Inc., disclaims beneficial ownership of the other
securities reported herein except to the extent of its pecuniary interests
as the managing general partner of Morgan Stanley Venture Partners II,
L.P., the General Partner of the Funds.
/s/ Peter Vogelsang
-------------------------------
**Signature of Reporting Person
By: Peter Vogelsang,
authorized signatory for Morgan
Stanley Dean Witter & Co.
/s/ Debra Abramovitz 12/8/00
------------------------------- ------------------------
**Signature of Reporting Person Date
By: Debra Abramovitz, Vice President
and Treasurer of Morgan Stanley Dean
Venture Capital II, Inc.,
the managing general partner of the
General Partner of the Funds.
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
Page 2
SEC 1474 (7-96)
<PAGE>
JOINT FILER INFORMATION
Each of the following joint filers has designated Morgan Stanley Venture
Capital II, Inc. ("MSVC II, Inc.") as the "Designated Filer" for purposes of
Item 1 of the attached Form 4:
(1) Morgan Stanley Dean Witter & Co. ("MSDW")
1585 Broadway
New York, New York 10036
(2) Morgan Stanley Venture Partners II, L.P. ("MSVP II, L.P.")
1221 Avenue of the Americas
New York, New York 10020
(3) Morgan Stanley Venture Capital Fund II Annex, L.P.
("MSVCF IIA, L.P.")
1221 Avenue of the Americas
New York, New York 10020
(4) Morgan Stanley Venture Investors Annex, L.P. ("MSVIA, L.P.")
1221 Avenue of the Americas
New York, New York 10020
Issuer & Ticker Symbol: Lionbridge Technologies, Inc. (LIOX)
Date of Event Requiring Statement: 11/00
Signature: /s/ Peter Vogelsang
-----------------------------------------------------
By: Peter Vogelsang, as authorized signatory for MSDW.
Signature: /s/ Debra Abramovitz
-----------------------------------------------------
By: Debra Abramovitz, Vice President and Treasurer of
MSVC II, Inc., the managing general partner of
MSVP II, L.P., the General Partner of MSVCF IIA,
L.P. and MSVIA, L.P.
